A phase III, multicenter, randomized, open label trial of [fam-] trastuzumab deruxtecan (DS-8201a) versus investigator's choice in HER2-low breast cancer Meeting Abstract
| Authors: | Modi, S.; Ohtani, S.; Lee, C. C.; Wang, K.; Saxena, K.; Cameron, D. A. |
| Abstract Title: | A phase III, multicenter, randomized, open label trial of [fam-] trastuzumab deruxtecan (DS-8201a) versus investigator's choice in HER2-low breast cancer |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 59s |
| Language: | English |
| ACCESSION: | WOS:000487345803222 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.TPS1102 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS1102 -- Source: Wos |
